Bfgf-Induced Angiogenesis in Ischemic Myocardium is Associated with Calreticulin Downregulation

Xiuhua Liu,Xudong Wu,Lirong Cai,Sheng Sun,Fengying Liu
DOI: https://doi.org/10.1016/j.yjmcc.2007.03.670
2007-01-01
Abstract:Basic fibroblast growth factor (bFGF) plays an integral role in therapeutic angiogenesis associated with myocardial infarct healing. Calreticulin, a 46-kDa Ca2+-binding chaperone mainly in the endoplasmic reticulum, plays an important role in regulating calcium homeostasis and anti-angiogenesis. To investigate the role of CRT in bFGF-induced angiogenesis and its signaling pathways in ischemic myocardium, two dimensional gel electrophoresis and MALDI-MS were employed to analyze CRT's differential expression in myocardial microvascular endothelial cells (MECs) treated with or without bFGF. Western blotting analysis was used to detect the expression of CRT and calcineurin (CaN) in sham-operated, bFGF- or saline-intramyocardial injected myocardium. It is found that bFGF induced significant angiogenesis after sustained ischemia with downregulation of CRT expression and upregulation of CaN expression in ischemic myocardium. The CRT expression was negatively correlated to myocardial angiogenesis. The results indicate that intramyocardial administration of bFGF decreases myocardial CRT expression in parallel with myocardial angiogenesis in ischemic myocardium. The study furthermore indicates that Ca2+/CaN signaling pathway may be involved in CRT-related angiogenesis.
What problem does this paper attempt to address?